NasdaqCM - Delayed Quote • USD
Benitec Biopharma Inc. (BNTC)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 7:34 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.78 | -0.4 | -2.43 | -1.75 |
| Low Estimate | -0.78 | -0.4 | -2.43 | -1.75 |
| High Estimate | -0.78 | -0.4 | -2.43 | -1.75 |
| Year Ago EPS | -2.72 | -2.83 | -14.12 | -2.43 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | 54k | 7k | 75k | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -3.4 | -3.23 | -0.51 | -0.39 |
| EPS Actual | -2.72 | -2.83 | -2.76 | -2.64 |
| Difference | 0.68 | 0.4 | -2.25 | -2.25 |
| Surprise % | 20.00% | 12.40% | -441.20% | -576.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.78 | -0.4 | -2.43 | -1.75 |
| 7 Days Ago | -0.78 | -0.49 | -2.95 | -2.56 |
| 30 Days Ago | -0.78 | -0.49 | -2.95 | -2.56 |
| 60 Days Ago | -0.78 | -0.49 | -2.95 | -2.56 |
| 90 Days Ago | -0.42 | -0.46 | -1.62 | -2.4 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | BNTC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 71.30% | -- | -- | 1.50% |
| Next Qtr. | 85.90% | -- | -- | 11.40% |
| Current Year | 82.80% | -- | -- | 5.20% |
| Next Year | 28.00% | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | JMP Securities: Market Outperform to Market Outperform | 4/22/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 2/15/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 1/24/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 9/26/2023 |
Related Tickers
BPTH Bio-Path Holdings, Inc.
2.4900
-7.26%
PALI Palisade Bio, Inc.
6.35
+7.26%
NKGN NKGen Biotech, Inc.
1.7100
-7.57%
ALRN Aileron Therapeutics, Inc.
4.9300
+3.79%
MLEC Moolec Science SA
1.4600
-15.61%
VNDA Vanda Pharmaceuticals Inc.
4.5600
-1.51%
CLNN Clene Inc.
0.3370
+0.57%
SILO Silo Pharma, Inc.
1.8800
+5.62%
PXMD PaxMedica, Inc.
0.6920
-3.35%
PHIO Phio Pharmaceuticals Corp.
0.6710
-4.25%